Fig. 1From: Randomized placebo control study of insulin sensitizers (Metformin and Pioglitazone) in psoriasis patients with metabolic syndrome (Topical Treatment Cohort)Flowchart of the patients enrolled in the study depicting enrollment, withdrawal and follow up of the subjectsBack to article page